Author: Alan Condon

The European Commission recently approved Zolgensma, Novartis' $2.1 million gene therapy drug for spinal muscular atrophy, for infants and children up to 46 pounds.

Neurosurgeon Jeffrey Gross, MD, has been selected to serve as chairperson volunteer medical liaison for the Newport Beach (Calif.) Covid Safe Commerce Task Force, KTVN reports.

Dubois, Pa.-based Penn Highlands Healthcare is beginning construction on a multistory building that will house The Brain and Spine Center and an orthopedic Center of Excellence, Connect FM radio reports.

Vero Beach, Fla.-based Vero Orthopaedics & Neurology recently restarted elective surgeries.

Orthobiologics company Cerapedics published data from a clinical trial examining the fusion rate of its i-Factor bone graft in noninstrumented lumbar fusion.

Fort Worth (Texas) Brain and Spine Institute recently partnered with eMDs, which provides EHR, practice management and revenue cycle management solutions for medical practices.

NuVasive's radiation reduction device LessRay recently won the "Best New Imaging Technology Solution" honor at the 2020 MedTech Breakthrough Awards.  

The number of spine surgeries performed at hospitals in the U.S. decreased 45 percent from March 1 to April 15, compared to the same period in 2019, Axios reports.

Medtronic on May 19 launched the Kyphon Assist Directional Cannula for balloon kyphoplasty procedures.

Orthopedic device manufacturer Implanet entered into exclusive negotiations May 18 to sell its Madison total knee implant.